| Symphogen A/S. (4/3/20). "Press Release: Servier Signed a Definitive Agreement to Acquire Symphogen, a Leading Antibody Discovery Company, to Boost Its Antibody Capabilities and Leverage Its R&D Pipeline". Paris & Copenhagen. |
2020-04-03 |
| Evotec SE. (4/2/20). "Press Release: Evotec Expands Its iPSC-based Cell Therapy Platform Evocells through Licensing Agreement with PanCella". Hamburg & Toronto. |
2020-04-02 |
| iTeos Therapeutics S.A.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. |
2020-04-01 |
| AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht. |
2020-03-31 |
| Evotec SE. (3/31/20). "Press Release: Evotec and Ildong to Collaborate with Development Projects on INDiGO Platform". Hamburg. |
2020-03-31 |
| InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. |
2020-03-31 |
| Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. |
2020-03-31 |
| BioNTech SE. (3/31/20). "Press Release: BioNTech Announces Full Year 2019 Financial Results and Corporate Update". Mainz. |
2020-03-31 |
| Numab Therapeutics AG. (3/30/20). "Press Release: Numab Therapeutics Expands Immuno-Oncology Research Alliance with Ono Pharmaceutical Co., Ltd.". Wädenswil (Zurich). |
2020-03-30 |
| Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
| H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Reports Headline Results from Phase IIa AMBLED study of Foliglurax in Parkinson’s Disease". Valby. |
2020-03-27 |
| Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". |
2020-03-26 |
| SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. |
2020-03-26 |
| Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. |
2020-03-26 |
| Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried. |
2020-03-26 |
| Forge Therapeutics, Inc.. (3/25/20). "Press Release: Forge Enters into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections". San Diego, CA. |
2020-03-25 |
| Debiopharm International SA. (3/25/20). "Press Release: Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-licensing Agreement of 3B Pharmaceutical’s Targeted CAIX Radiotherapy". Lausanne. |
2020-03-25 |
| MedinCell S.A.. (3/25/20). "Press Release: MedinCell Receives $ 6.4 Million Grant from Unitaid to Fight Malaria". Montpellier. |
2020-03-25 |
| ProBioGen AG. (3/24/20). "Press Release: Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Houston, TX. |
2020-03-24 |
| Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. |
2020-03-24 |
| Bayer AG. (23/3/20). "Press Release: Bayer and Curadev Sign Research Collaboration and License Agreement to Develop Novel STING Antagonists across Indications". Berlin & New Delhi. |
2020-03-23 |
| Proteona Pte. Ltd.. (23/3/20). "Press Release: One More Step towards True Precision Medicine. Proteona, Synovo, and NMI Announced Collaboration on a Single Cell Multi-omics Profiling Platform for Patient-derived Micro-tumors". Singapore. |
2020-03-23 |
| Genedata AG. (3/23/20). "Press Release: CytomX Therapeutics Deploys Genedata Bioprocess". South San Francisco, CA & Tokyo. |
2020-03-23 |
| AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. |
2020-03-23 |
| Eppendorf AG. (3/19/20). "Press Release: Eppendorf Acquires Centrifuge Business of Koki Holdings Co., Ltd.". Hamburg & Tokyo. |
2020-03-19 |
| OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. |
2020-03-18 |
| Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform". |
2020-03-17 |
| Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. |
2020-03-17 |
| BioNTech SE. (3/17/20). "Press Release: Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine". New York, NY & Mainz. |
2020-03-17 |
| ImCheck Therapeutics S.A.S.. (3/17/20). "Press Release: ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer". Marseille. |
2020-03-17 |
| Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. |
2020-03-17 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech Reports Rapid Progress on COVID-19 Vaccine Program to Address Global Public Health Threat". Mainz. |
2020-03-16 |
| CureVac AG. (3/16/20). "Press Release: CureVac Announces Leadership Update". Tübingen & Boston, MA. |
2020-03-16 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech and Fosun Pharma Form COVID-19 Vaccine Strategic Alliance in China". Mainz & Shanghai. |
2020-03-16 |
| CureVac AG. (3/15/20). "Press Release: CureVac Focuses on the Development of mRNA-based Coronavirus Vaccine to Protect People Worldwide. The Company Rejects Current Rumors of an Acquisition". Tübingen & Boston, MA. |
2020-03-15 |
| dievini Hopp BioTech holding GmbH & Co. KG. (3/15/20). "Press Release: dievini nimmt Stellung zu Presseveröffentlichungen über ihre Beteiligungsgesellschaft". Walldorf. |
2020-03-15 |
| CureVac AG. (3/11/20). "Press Release: Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG". Tübingen & Boston, MA. |
2020-03-11 |
| Life Science Nord Management GmbH. (3/11/20). "Press Release: Innovation Project Started – Digital Precision Medicine Made in Northern Germany". |
2020-03-11 |
| MedDay Pharmaceuticals S.A.S.. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris. |
2020-03-10 |
| Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. |
2020-03-10 |
| Calixar S.A.S.. (3/9/20). "Press Release: Calixar Launches New Funding Round to Establish Business Strategy". Lyon. |
2020-03-09 |
| Numab Therapeutics AG. (3/9/20). "Press Release: Numab Therapeutics Closes Series B Financing at CHF 22M to Advance Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil (Zurich). |
2020-03-09 |
| High-Tech Gründerfonds Management GmbH. (3/9/20). "Press Release: High-Tech Gründerfonds and Bayern Kapital Invest in Digital Cardiology Clinic iAtros". |
2020-03-09 |
| UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. |
2020-03-09 |
| Biotalys N.V.. (3/5/20). "Press Release: Biotalys Announces Second Closing of €45 Million Series C Financing Round". Ghent. |
2020-03-05 |
| Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. |
2020-03-05 |
| Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen. |
2020-03-05 |
| Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen. |
2020-03-05 |
| Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. |
2020-03-04 |
| Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. |
2020-03-04 |
| Voluntis S.A.. (3/3/20). "Press Release: Voluntis and Bristol-Myers Squibb to Co-develop Digital Therapeutics for Oncology". New York, NY & Paris. |
2020-03-03 |
| Qiagen N.V.. (3/3/20). "Press Release: Conclusion of a Business Combination Agreement between Qiagen N.V. and Thermo Fisher Scientific Inc., Announcement of a Public Tender Offer by Thermo Fisher Scientific Inc. [Ad hoc]". Venlo. |
2020-03-03 |
| Qiagen N.V.. (3/3/20). "Press Release: Thermo Fisher Scientific to Acquire Qiagen N.V.". Waltham, MA & Venlo. |
2020-03-03 |
| Uniqure N.V.. (3/2/20). "Press Release: Uniqure Announces 2019 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2020-03-02 |
| MorphoSys AG. (3/2/20). "Press Release: FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory DLBCL". Planegg. |
2020-03-02 |
| Uniqure N.V.. (3/2/20). "Press Release: Uniqure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters". Lexington, MA & Amsterdam. |
2020-03-02 |
| CureVac AG. (3/2/20). "Press Release: CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force". Tübingen. |
2020-03-02 |
| Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt. |
2020-03-02 |
| Boehringer Ingelheim. (2/28/20). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease". Ingelheim. |
2020-02-28 |
| MGI Tech Co., Ltd.. (2/27/20). "Press Release: MGI and Sophia Genetics Partner to Provide Solutions to Interpret Genomic Data". San José, CA. |
2020-02-27 |
| Merck KGaA. (2/27/20). "Press Release: Merck and AMCM / EOS Cooperate in 3D Printing of Tablets". Darmstadt. |
2020-02-27 |
| Boehringer Ingelheim. (2/27/20). "Press Release: Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform". Ingelheim & San Diego, CA. |
2020-02-27 |
| iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies. |
2020-02-27 |
| Nouscom AG. (2/26/20). "Press Release: Nouscom Strengthens Its Management Team. Marina Udier, PhD Appointed as Chief Executive Officer and Patricia Delaite, MD Appointed as Chief Medical Officer". Basel. |
2020-02-26 |
| CRISPR Therapeutics AG. (2/26/20). "Press Release: CRISPR Therapeutics Proposes Changes to the Board of Directors". Zug & Cambridge, MA. |
2020-02-26 |
| CureVac AG. (2/26/20). "Press Release: CureVac Appoints Alan Kimura, MD, PhD as Head of the Newly Created Department “Rare Diseases”". Tübingen & Boston, MA. |
2020-02-26 |
| Twist Bioscience Corporation. (2/26/20). "Press Release: Twist Bioscience and Sophia Genetics Collaborate to Offer Optimized Genomic Solutions". South San Francisco, CA. |
2020-02-26 |
| Scipio Bioscience. (2/25/20). "Press Release: Scipio Bioscience Raises €6.0 M Series A Financing". Paris. |
2020-02-25 |
| ProBioGen AG. (2/25/20). "Press Release: ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Schlieren. |
2020-02-25 |
| Sanofi S.A.. (2/24/20). "Press Release: Sanofi to Create New Industry Leading European Company to Provide Active Pharmaceutical Ingredients (API)". Paris. |
2020-02-24 |
| Yposkesi. (2/24/20). "Press Release: Yposkesi Welcomes Patrick Lansky as VP of US Sales & Marketing". Corbeil-Essonnes. |
2020-02-24 |
| DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. |
2020-02-21 |
| Adrenomed AG. (2/21/20). "Press Release: Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock". Hennigsdorf. |
2020-02-21 |
| Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. |
2020-02-20 |
| Sophia Genetics S.A.. (2/20/20). "Press Release: Sophia Genetics’ Board of Directors Elects Troy Cox as New Chairman". Lausanne & Boston, MA. |
2020-02-20 |
| CTC North GmbH & Co. KG. (2/20/20). "Press Release: Hope for Hepatitis B Patients. New Research Project to Cure Hepatitis B Patients under the European Horizon 2020 Programme". |
2020-02-20 |
| Merck KGaA. (2/19/20). "Press Release: Merck Divests Allergopharma to Dermapharm Holding SE". Darmstadt. |
2020-02-19 |
| France Biotech. (2/19/20). "Press Release: Driven by Its Successful Debut, the Second Annual International HealthTech Innovation Days Will Take Place in Paris on June 22nd & 23rd". Paris. |
2020-02-19 |
| Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. |
2020-02-18 |
| Cellectis S.A.. (2/18/20). "Press Release: Cellectis and Servier Expand Collaboration on UCART19 Products". New York, NY. |
2020-02-18 |
| Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel. |
2020-02-17 |
| o2h Ventures. (2/15/20). "Press Release: o2h Ventures Is Pleased to Announce an Investment in Neurofenix, an Innovative Digital Health Company". Cambridge. |
2020-02-15 |
| OncoDNA S.A.. (2/14/20). "Press Release: OncoDNA Closes Successful Series B Investment Round". Gosselies. |
2020-02-14 |
| Sophia Genetics S.A.. (2/13/20). "Press Release: Sophia Genetics Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy. Dr. Philippe Menu Joins Sophia Genetics". Lausanne & Boston, MA. |
2020-02-13 |
| CRISPR Therapeutics AG. (2/12/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results". Zug & Cambridge, MA. |
2020-02-12 |
| OSE Immunotherapeutics S.A.. (2/12/20). "Press Release: OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico". Nantes. |
2020-02-12 |
| ProteoMedix AG. (2/11/20). "Press Release: New Data from Proclarix together with Magnetic Resonance Imaging (MRI) for Improved Prostate Cancer Diagnosis to Be Showcased at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium". Zür |
2020-02-11 |
| Stilla Technologies S.A.S.. (2/11/20). "Press Release: Stilla Technologies Raises €20 Million ($22 Million) in Series B Round that Brings in New Investor, TUS-Holdings, alongside Existing Ones". Paris. |
2020-02-11 |
| ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. |
2020-02-11 |
| Bayer AG. (2/11/20). "Press Release: Bayer and Nuvisan Create New Research Unit in Berlin". Berlin. |
2020-02-11 |
| Bayer AG. (2/10/20). "Press Release: Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies". Monheim & Paris. |
2020-02-10 |
| Roche. (2/10/20). "Press Release: Roche Provides Topline Results from Investigator-led Phase II/III Trial with Gantenerumab in Rare Inherited Form of Alzheimer’s Disease". Basel. |
2020-02-10 |
| Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne. |
2020-02-06 |
| Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. |
2020-02-06 |
| Roche. (2/6/20). "Press Release: Roche’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 with Type 2 or 3 Spinal Muscular Atrophy". Basel. |
2020-02-06 |
| PentixaPharm GmbH. (2/6/20). "Press Release: PentixaPharm Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics". Würzburg. |
2020-02-06 |
| Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA. |
2020-02-05 |
| MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. |
2020-02-05 |
| Inato. (2/4/20). "Press Release: Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures". Paris. |
2020-02-04 |
| MorphoSys AG. (2/4/20). "Press Release: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.". Planegg. |
2020-02-04 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
